A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction

American Journal of Medicine

Volumn 116, Issue 5, 2004, Pages 300-304

  Brophy, James M ^a,e   Dagenais, Gilles R ^b   McSherry, Frances ^c   Williford, William ^c   Yusuf, Salim ^d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c VA Medical Center   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMEGALY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SINUS RHYTHM; STATISTICAL MODEL; SURVIVAL; SYSTOLE; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 1242270609     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.09.035     Document Type: Article

References (21)

1. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, Texas: American Heart Association. Available at: http://www.americanheart.org/statistics/ . Accessed October 27, 2003.
2. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States a manifestation of coronary artery disease . Circulation. 97:1998;282-289.
3. Graves E.J. National Hospital Discharge Survey Annual Summary, 1993 . National Health Survey. 121:1995;1-63. Vital and Health Statistics Series, No. 13.
4. Garg R., Yusuf S. Overview of randomized trials of angiotensin- converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 273:1995;1450-1456.
5. Evaluation and management of heart failure. J Am Coll Cardiol. 26:1995;1376-1398.
6. Krumholz H.M., Baker D.W., Ashton C.M., et al. Evaluating quality of care for patients with heart failure. Circulation. 101:2000;e122-e140.
7. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure . Control Clin Trials. 17:1996;77-97.
8. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 336:1997;525-533.
9. Raftery A.E. Bayesian model selection in social research (with discussion by Andrew Gelman, Donald B. Rubin, and Robert M. Hauser). Marsden P.V. Sociological Methodology. 1995;111-196 Blackwell, Oxford, United Kingdom.
10. Eichhorn E.J. Prognosis determination in heart failure. Am J Med. 110:(suppl 7A):2001;14S-36S.
11. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 88:1993;107-115.
12. Cohn J.N. Prognosis in congestive heart failure. J Card Fail. 2:(suppl):1996;S225-S229.
13. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 35:2000;681-689.
14. Philbin E.F., Garg R., Danisa K., et al. The relationship between cardiothoracic ratio and left ventricular ejection fraction in congestive heart failure. Digitalis Investigation Group. Arch Intern Med. 158:1998;501-506.
15. Drazner M.H., Rame J.E., Stevenson L.W., Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 345:2001;574-581.
16. Bart B.A., Shaw L.K., McCants C.B.J.r, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 30:1997;1002-1008.
17. Gavazzi A., Berzuini C., Campana C., et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart Lung Transplant. 16:1997;774-785.
18. Dries D.L., Sweitzer N.K., Drazner M.H., Stevenson L.W., Gersh B.J. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 38:2001;421-428.
19. Auerbach A.D., Hamel M.B., Davis R.B., et al. Resource use and survival of patients hospitalized with congestive heart failure differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments . Ann Intern Med. 132:2000;191-200.
20. McAlister F.A., Lawson F.M., Teo K.K., Armstrong P.W. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 110:2001;378-384.
21. Brophy J.M., Joseph L., Rouleau J.L. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 134:2001;550-560.